 random trial cisplatin vinblastin versu vinblastin cisplatin treatment advanc germ cell tumor testi southwest oncolog group studi southwest oncolog group swog trial cisplatin vinblastin bleomycin pvb versu vinblastin cisplatin vpv treatment advanc germ cell tumor testi studi object effect replac bleomycin complet respons CR surviv drug toxic sixty-nin patient patient assess respons dissemin germ cell neoplasm testicular origin forty-six minim metastat diseas maxim diseas seventy-seven pvb vpv chemotherapi signific differ pretreat characterist arm regard burden histolog type overal perform statu patient cours induct chemotherapi pvb cisplatin day vinblastin day week vpv vinblastin day cisplatin day day chemotherapi week cytoreduct surgeri postinduct chemotherapi CR differ percentag patient disease-fre statu pvb vpv mean leukocyt nadir similar treatment mean platelet nadir vpv arm bleomycin-rel toxic pulmonari mucos skin vpv arm bleomycin first-lin therapi advanc germ cell tumor efficaci advantag unnecessari drug toxic